BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33278559)

  • 1. Diverse origins and activation of fibroblasts in cardiac fibrosis.
    Aujla PK; Kassiri Z
    Cell Signal; 2021 Feb; 78():109869. PubMed ID: 33278559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies.
    Liu M; López de Juan Abad B; Cheng K
    Adv Drug Deliv Rev; 2021 Jun; 173():504-519. PubMed ID: 33831476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated fibroblasts in cardiac and cancer fibrosis: An overview of analogies and new potential therapeutic options.
    Nicolini G; Balzan S; Forini F
    Life Sci; 2023 May; 321():121575. PubMed ID: 36933828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling.
    Svystonyuk DA; Ngu JM; Mewhort HE; Lipon BD; Teng G; Guzzardi DG; Malik G; Belke DD; Fedak PW
    J Transl Med; 2015 May; 13():147. PubMed ID: 25948488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
    Frangogiannis NG
    Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis.
    Molkentin JD; Bugg D; Ghearing N; Dorn LE; Kim P; Sargent MA; Gunaje J; Otsu K; Davis J
    Circulation; 2017 Aug; 136(6):549-561. PubMed ID: 28356446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host responses in tissue repair and fibrosis.
    Duffield JS; Lupher M; Thannickal VJ; Wynn TA
    Annu Rev Pathol; 2013 Jan; 8():241-76. PubMed ID: 23092186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart.
    Miller CL; Cai Y; Oikawa M; Thomas T; Dostmann WR; Zaccolo M; Fujiwara K; Yan C
    Basic Res Cardiol; 2011 Nov; 106(6):1023-39. PubMed ID: 22012077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Fibrosis and Fibroblasts.
    Kurose H
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease.
    Kramann R; DiRocco DP; Humphreys BD
    J Pathol; 2013 Nov; 231(3):273-89. PubMed ID: 24006178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac fibroblasts: from development to heart failure.
    Moore-Morris T; Guimarães-Camboa N; Yutzey KE; Pucéat M; Evans SM
    J Mol Med (Berl); 2015 Aug; 93(8):823-30. PubMed ID: 26169532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac fibrosis.
    Frangogiannis NG
    Cardiovasc Res; 2021 May; 117(6):1450-1488. PubMed ID: 33135058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure.
    Nagaraju CK; Robinson EL; Abdesselem M; Trenson S; Dries E; Gilbert G; Janssens S; Van Cleemput J; Rega F; Meyns B; Roderick HL; Driesen RB; Sipido KR
    J Am Coll Cardiol; 2019 May; 73(18):2267-2282. PubMed ID: 31072570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myofibroblast modulation of cardiac myocyte structure and function.
    Nagaraju CK; Dries E; Gilbert G; Abdesselem M; Wang N; Amoni M; Driesen RB; Sipido KR
    Sci Rep; 2019 Jun; 9(1):8879. PubMed ID: 31222006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndecans in heart fibrosis.
    Lunde IG; Herum KM; Carlson CC; Christensen G
    Cell Tissue Res; 2016 Sep; 365(3):539-52. PubMed ID: 27411689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblasts and the extracellular matrix in right ventricular disease.
    Frangogiannis NG
    Cardiovasc Res; 2017 Oct; 113(12):1453-1464. PubMed ID: 28957531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium.
    Dobaczewski M; de Haan JJ; Frangogiannis NG
    J Cardiovasc Transl Res; 2012 Dec; 5(6):837-47. PubMed ID: 22956156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGFβ signalling in cardiac fibroblasts.
    Rypdal KB; Erusappan PM; Melleby AO; Seifert DE; Palmero S; Strand ME; Tønnessen T; Dahl CP; Almaas V; Hubmacher D; Apte SS; Christensen G; Lunde IG
    Sci Rep; 2021 Oct; 11(1):19757. PubMed ID: 34611183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.
    Stratton MS; Bagchi RA; Felisbino MB; Hirsch RA; Smith HE; Riching AS; Enyart BY; Koch KA; Cavasin MA; Alexanian M; Song K; Qi J; Lemieux ME; Srivastava D; Lam MPY; Haldar SM; Lin CY; McKinsey TA
    Circ Res; 2019 Sep; 125(7):662-677. PubMed ID: 31409188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.